n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JH; Ha, NR; Lee, SC; Lee, SJ; Yoon, MY | 1 |
| Gong, Y; He, Q; Huang, Y; Zhang, ZR | 1 |
2 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Breast Neoplasms
| Article | Year |
|---|---|
A novel peptide-based recognition probe for the sensitive detection of CD44 on breast cancer stem cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Combinatorial Chemistry Techniques; Early Detection of Cancer; Female; Flow Cytometry; Humans; Hyaluronan Receptors; MCF-7 Cells; Mice; Molecular Diagnostic Techniques; Neoplastic Stem Cells; NIH 3T3 Cells; Peptides; Sensitivity and Specificity; Succinimides | 2015 |
[Conjugation of mitoxantrone-loaded nanospheres and anti-C-erbB-2 monoclonal antibodies].
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Immunotoxins; Microspheres; Mitoxantrone; Nanotechnology; Receptor, ErbB-2; Succinimides; Tumor Cells, Cultured | 2001 |